Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Aims To Sway Hospitals On MIS Cost-Savings, Dismisses Charité

This article was originally published in The Gray Sheet

Executive Summary

Zimmer plans to drive hospital adoption of its MIS 2-Incision hip and MIS Quad-Sparing knee procedures by touting their ability to spur hospital profits

You may also be interested in...



Artificial Disc Designs To Converge In A Decade – Spine Surgeon Sasso

Despite wide variations in the designs of lumbar and cervical artificial discs, device firms will eventually move toward more unified platforms for each as the market matures, Rick Sasso, MD, Indiana Spine Group, believes

Artificial Disc Designs To Converge In A Decade – Spine Surgeon Sasso

Despite wide variations in the designs of lumbar and cervical artificial discs, device firms will eventually move toward more unified platforms for each as the market matures, Rick Sasso, MD, Indiana Spine Group, believes

Ortho Firms Feel DoJ Probe Price As Stocks Fall In Q1; Will Zimmer Diversify?

The federal government's mounting scrutiny of orthopedic industry pricing practices for hip and knee replacement implants could convince Zimmer to more aggressively seek a presence in the artificial disc arena

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel